Loading the section
Closing prices for 09 October 2026
Next earnings report: 04 November 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Royalty Pharma plc trades on Nasdaq under the ticker RPRX. The company belongs to the Health care sector. The trading history on this page starts on 16 June 2020.
Over the past 52 weeks RPRX has traded between 35.23 $ and 64.38 $. As of 09 October 2026 the price stood 74.44 % of the way from the 52-week low to the high.
Over one year RPRX shares rose 58.05 %; over six months they rose 18.85 %. Volatility over 90 days is 24.28 %. Dividends are not included: this is price change only, as of 09 October 2026.
RPRX trades at a price-to-earnings ratio of 37.8, above the sector median of 24.8. Price to sales is 12.8, above the sector median of 3.9. Price to book is 3.1, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 56.03 | 57.08 | 55.72 | 56.93 | 3M |
| 08 October 2026 | 56.57 | 56.71 | 55.13 | 56.21 | 3M |
| 07 October 2026 | 56.61 | 57.16 | 56.41 | 56.76 | 4M |
| 06 October 2026 | 56.66 | 57.13 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.
Royalty Pharma buys the right to a share of sales of already-approved drugs — it researches and manufactures nothing.
A university or biotech that invented a drug receives royalties from whoever sells it. Royalty Pharma buys that future stream for a lump sum: the seller gets money today and sheds the risk, the buyer gets years of income without laboratories, factories or a sales force.
The portfolio is assembled so that no single drug decides the company's fate. The main risks lie elsewhere: patent expiry, which ends a stream on schedule, and competition for deals, which raises acquisition prices. Such a stock is better assessed as a portfolio of rights with known end dates than as a pharmaceutical company. Dividends are paid regularly.
Address:110 EAST 59TH STREET, NEW YORK, NY, 10022, US
Royalty Pharma plc reported revenue of 2.4B $ and net income of 827M $ over the last four quarters. Net margin is 33.90 %. Revenue changed by +7.80 % year over year. Earnings per share are 1.90 $. Market capitalisation is 31.2B $.
RPRX has a return on equity of 8.33 %, above the sector median of −41.68 %. Return on assets is 4.17 %, above the sector median of −32.11 %. Operating margin is 65.08 %, above the sector median of −26.84 %.
Royalty Pharma plc pays dividends quarterly: 0.93 $ per share over the past twelve months, a yield of 1.65 %. The latest payment was 0.24 $, with an ex-dividend date of 14 August 2026. The company has raised its payout for 5 years in a row.
| 1.2B |
| PFEPfizer, Inc. | 28.18 | +1.28 % | 929M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 56.04 |
| 56.44 |
| 2M |
| 05 October 2026 | 57.10 | 57.25 | 56.01 | 56.66 | 4M |
| 02 October 2026 | 57.64 | 57.91 | 56.96 | 57.16 | 2M |
| 01 October 2026 | 58.36 | 58.40 | 57.22 | 57.63 | 3M |
| 30 September 2026 | 58.07 | 58.64 | 57.70 | 58.36 | 4M |
| 29 September 2026 | 58.19 | 58.48 | 57.51 | 58.22 | 3M |
| 28 September 2026 | 57.88 | 58.77 | 57.63 | 58.37 | 2M |
| 25 September 2026 | 58.50 | 58.50 | 57.68 | 58.21 | 2M |
| 24 September 2026 | 57.69 | 58.87 | 57.66 | 58.29 | 2M |
| 23 September 2026 | 58.52 | 59.02 | 57.63 | 57.65 | 3M |
| 22 September 2026 | 58.27 | 59.03 | 57.86 | 58.52 | 3M |
| 21 September 2026 | 58.56 | 59.07 | 57.82 | 58.44 | 3M |
| 18 September 2026 | 58.63 | 58.96 | 57.97 | 58.41 | 7M |
| 17 September 2026 | 58.81 | 59.18 | 58.46 | 58.93 | 2M |
| 16 September 2026 | 59.00 | 59.17 | 58.27 | 58.47 | 2M |
| 15 September 2026 | 59.00 | 59.20 | 57.91 | 58.47 | 3M |
| 14 September 2026 | 58.66 | 59.55 | 57.75 | 59.05 | 3M |